$MRK
Merck & Co., Inc.
NYSE · Healthcare · Pharmaceutical Preparations · Rahway, NJ
MRK chart
What traders are saying about $MRK
Latest postsMerck & Co., Inc. news
- 4 Blue-Chip Dividend Stocks That Could Turn $200,000 Into Annual Retirement Income
247wallst.com ·
- Has Regeneron Stock Become A Different Bet?
trefis.com ·
- HSBC raises target for Merck & Co. stock to USD 175.00
ad-hoc-news.de ·
- Scancell cancer vaccine strategy backed by Moderna and Merck trial results
proactiveinvestors.com ·
- Gilead to Report Q3 Earnings: How Should You Play the Stock Now?
Yahoo Finance ·
- What's in Store for These 5 Drug/Biotech Stocks in Q3 Earnings?
Yahoo Finance ·
- Moderna shares slip as William Blair cuts rating on valuation after rally
Yahoo Finance ·
- Pfizer (PFE) Expected to Beat Earnings Estimates: Should You Buy?
Yahoo Finance ·
- Moderna’s CEO Gives an Inside Look at the Biotech’s New Era
Yahoo Finance ·
- ESMO Spotlight: Merck & Co. builds further evidence for sac-TMT as a post-Keytruda growth driver
FirstWord Pharma ·
- Entera Appoints Global Research and Development Leader Dr. Juan Camilo Arjona Ferreira to Its Board of Directors
Yahoo Finance ·
- Is Merck Stock a Buy, Sell or Hold Ahead of Q3 Earnings?
Yahoo Finance ·
Merck & Co., Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $65.01B | $64.17B | $60.12B | $59.28B |
| Net income | $18.25B | $17.12B | $365.0M | $14.52B |
| Diluted EPS | $7.28 | $6.74 | $0.14 | $5.71 |
| Total assets (year end) | $136.87B | $117.11B | $106.67B | $109.16B |
| Cash and equivalents (year end) | $14.56B | $13.24B | $6.84B | $12.69B |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 8-K8-K
- 10-Q10-Q
- 8-KFORM 8-K
- 8-KFORM 8-K
- 8-K8-K
- 10-Q1Q26 FORM 10-Q
- 8-KFORM 8-K
- DEF 14ADEF 14A
- 10-K10-K FOR THE FISCAL YEAR ENDED DECEMBER 31, 2025
- 8-KFORM 8-K
- 8-K8-K
- 10-Q3Q25 FORM 10-Q
About Merck & Co., Inc.
- Ticker
- MRK (NYSE)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Rahway, NJ
- Incorporated in
- NJ
- Fiscal year end
- December 31
- SEC CIK
- 310158
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
Frequently asked questions
What exchange is Merck & Co., Inc. listed on?
Merck & Co., Inc. trades on the NYSE under the ticker symbol MRK.
What industry is Merck & Co., Inc. in?
Merck & Co., Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Merck & Co., Inc. headquartered?
Merck & Co., Inc.'s business address on file with the SEC is in Rahway, NJ.
When does Merck & Co., Inc.'s fiscal year end?
Merck & Co., Inc.'s fiscal year ends on December 31.
How much revenue did Merck & Co., Inc. report?
Merck & Co., Inc. reported $65.01B in revenue for calendar year 2025, according to its SEC filings.